Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha-Reference-Cited by-同舟云学术

Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha

Published:2013-09-10 Issue:4 Volume:134 Page:988-996
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

El Eit Rabab M.¹,Iskandarani Ahmad N.¹,Saliba Jessica L.¹,Jabbour Mark N.²,Mahfouz Rami A.²,Bitar Nizar M.A.³,Ayoubi Hanadi R. El⁴,Zaatari Ghazi S.²,Mahon Francois-Xavier⁵,De Thé Hugues B.⁶,Bazarbachi Ali A.¹⁷,Nasr Rihab R.¹

Affiliation:

1. Department of Anatomy; Cell Biology and Physiology, American University of Beirut; Beirut Lebanon

2. Department of Pathology and Laboratory Medicine; American University of Beirut; Beirut Lebanon

3. Hematology-Oncology Internal Medicine Lebanese University; Faculty of Medical Sciences Sahel General Hospital; Beirut Lebanon

4. Hamad Medical Corporation; Doha Qatar

5. Laboratoire d'Hématologie et Service des Maladies du Sang; CHU de Bordeaux, Université Victor Ségalen Bordeaux 2, INSERM U876; Bordeaux France

6. Service de Biochimie, Equipe labellisée; Ligue Nationale Contre le Cancer, CNRS/INSERM/Université Paris Diderot UMR 7212, Hôpital Saint Louis; Paris France

7. Department of Internal Medicine; American University of Beirut; Beirut Lebanon

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.28427/fullpdf

Reference50 articles.

1. European LeukemiaNet. Chronic myeloid leukaemia;Hehlmann;Lancet,2007

2. European LeukemiaNet. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet;Baccarani;J Clin Oncol,2009

3. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome;Druker;N Engl J Med,2001

4. BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet;Soverini;Blood,2011

5. Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment;Chu;Blood,2011

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arsenic Trioxide: Pharmacological Applications;Vitae;2023-04-20

2. In the Pipeline: Emerging Therapy for CML;Pathogenesis and Treatment of Leukemia;2023

3. Modulation of Different Signaling Pathways in Liver Cancer by Arsenic Trioxide;Arsenic Toxicity Remediation: Biotechnological Approaches;2023

4. High-Throughput CRISPR Screening in Hematological Neoplasms;Cancers;2022-07-25

5. Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms;International Journal of Molecular Sciences;2021-01-11